Sakar Healthcare Ltd Share Price

324.9
(-0.85%)
Jul 23, 2024|03:32:35 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open330
  • Day's High333.05
  • 52 Wk High479
  • Prev. Close327.7
  • Day's Low321
  • 52 Wk Low249.1
  • Turnover (lac)58.98
  • P/E61.02
  • Face Value10
  • Book Value119.75
  • EPS5.37
  • Mkt. Cap (Cr.)706.65
  • Div. Yield0
No Records Found

Sakar Healthcare Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

330

Prev. Close

327.7

Turnover(Lac.)

58.98

Day's High

333.05

Day's Low

321

52 Week's High

479

52 Week's Low

249.1

Book Value

119.75

Face Value

10

Mkt Cap (₹ Cr.)

706.65

P/E

61.02

EPS

5.37

Divi. Yield

0

Sakar Healthcare Ltd Corporate Action

20 Jul 2023

12:00 AM

BookCloser

arrow

22 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

27 Nov 2023

12:00 AM

EGM

arrow

20 Jul 2023

12:00 AM

AGM

Announcement Date: 20 Jul, 2023

arrow

Sakar Healthcare Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sakar Healthcare Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|04:21 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 53.15%

Foreign: 0.00%

Indian: 53.15%

Non-Promoter- 24.13%

Institutions: 24.13%

Non-Institutions: 22.70%

Custodian: 0.00%

Share Price

Sakar Healthcare Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

19.04

17.12

15.62

14.96

Preference Capital

0

0

0

0

Reserves

154.39

110.42

82.84

66.36

Net Worth

173.43

127.54

98.46

81.32

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

94.73

82.98

53.07

44.17

yoy growth (%)

14.17

56.34

20.16

7.14

Raw materials

-51.11

-43.04

-27.99

-22.28

As % of sales

53.95

51.87

52.75

50.45

Employee costs

-13.25

-12.12

-6.83

-5.94

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

13.24

12.22

6.12

4.82

Depreciation

-8.05

-7.07

-4.4

-3.38

Tax paid

-2.55

-2.6

-2.29

-1.44

Working capital

-6.96

-4.37

-1.06

8.98

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

14.17

56.34

20.16

7.14

Op profit growth

15.68

55.25

23.85

21.84

EBIT growth

8.59

66.22

16.01

29.13

Net profit growth

11.11

152.25

12.91

52.31

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

153.35

133.36

128.23

94.74

Excise Duty

0

0

0

0

Net Sales

153.35

133.36

128.23

94.74

Other Operating Income

0

0

0

0

Other Income

3.18

4.67

2.17

1.18

Sakar Healthcare Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,587.35

124.833,80,990.4867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,534.8

76.421,20,383.365310.662,259507.93

Cipla Ltd

CIPLA

1,490

32.381,20,295.961,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,154.55

33.791,16,159.651,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,770.9

26.361,12,931.21,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Sakar Healthcare Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Sanjay S Shah.

Joint Managing Director

Aarsh S Shah

Whole-time Director

Ritaben S Shah

Independent Non Exe. Director

Shailesh B Patel

Independent Non Exe. Director

Prashant C Srivastav

Independent Non Exe. Director

Hemendrakumar C Shah

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Sakar Healthcare Limited was incorporated as a Private Limited Company under the name Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHO-GMP, CGMP & National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote divoire.In 2005, the Company started co
Read More

Company FAQs

What is the Sakar Healthcare Ltd share price today?

Down Arrow

The Sakar Healthcare Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹324.9 today.

What is the Market Cap of Sakar Healthcare Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sakar Healthcare Ltd is ₹706.65 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Sakar Healthcare Ltd?

Down Arrow

The PE and PB ratios of Sakar Healthcare Ltd is 61.02 and 2.72 as of 23 Jul ‘24

What is the 52 Week High and Low of Sakar Healthcare Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Sakar Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sakar Healthcare Ltd is ₹249.1 and ₹479 as of 23 Jul ‘24

What is the CAGR of Sakar Healthcare Ltd?

Down Arrow

Sakar Healthcare Ltd's CAGR for 5 Years at 41.41%, 3 Years at 24.33%, 1 Year at 26.70%, 6 Month at -21.42%, 3 Month at -8.54% and 1 Month at 3.90%.

What is the shareholding pattern of Sakar Healthcare Ltd?

Down Arrow

The shareholding pattern of Sakar Healthcare Ltd is as follows:
Promoters - 53.15 %
Institutions - 24.14 %
Public - 22.71 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.